Last reviewed · How we verify
NCT05281575
Evaluation of Baby Friendly Spaces in Cox's Bazar, Bangladesh.
NA trial testing Baby Friendly Spaces (BFS) in Psychosocial Functioning in 600 participants. Status unknown.
30 March 2022
Quick facts
| Lead sponsor | Action Contre la Faim |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | prevention |
| Enrollment | 600 |
| Start date | 28 November 2021 |
| Primary completion | 30 March 2022 |
| Estimated completion | 30 March 2022 |
| Sites | 1 location across Bangladesh |
Drugs / interventions tested
- Baby Friendly Spaces (BFS)
Conditions studied
- Psychosocial Functioning — all drugs for Psychosocial Functioning →
- Psychological Distress — all drugs for Psychological Distress →
Sponsor
Action Contre la Faim
Who can join
18 and older, female only, with Psychosocial Functioning or Psychological Distress. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The overarching goal of this study is to evaluate the effectiveness and implementation of the Baby Friendly Spaces (BFS) program for improvement of maternal psychosocial wellbeing among Rohingya refugee mothers and their malnourished infants and young children in Cox's Bazar, Bangladesh. The purpose of the BFS program is to provide convenient, accessible psychosocial support to mothers in order to facilitate their ability to care for their children. BFS activities include: counselling for infant and young child feeding practices, hygiene education and promotion, group discussions on parenting skills, mother-child bonding activities and maternal psychosocial support. In Cox's Bazar, the BFS program is not currently standardized as intended. In this study, integrated nutrition centers that offer the BFS program are being paired and randomized to receive re-training in a standardized and implementation-enhanced version of BFS (enhanced-BFS) or to continue BFS services as usual (TAU-BFS). Primary (symptoms of psychological distress and functional impairment) and secondary (subjective psychosocial wellbeing and coping) outcomes will be assessed immediately post intervention (8 weeks after initial baseline assessment) via interviewer-administered surveys. The central hypothesis is that mothers attending enhanced-BFS services will experience greater improvement in all psychosocial well-being indicators relative to mothers in the standard, treatment-as-usual centers.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Psychosocial impacts of Baby Friendly Spaces for Rohingya refugee mothers in Bangladesh: A pragmatic cluster-randomized controlled trial.
Nguyen AJ, Murray SM, Rahaman KS, Lasater ME, et al · · 2024 · cited 4× · PMID 38827334 · DOI 10.1017/gmh.2024.58
Verify or expand the search:
- PubMed search for NCT05281575
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Psychosocial Functioning
Currently open trials in the same condition.
- NCT07130981 — Body Composition and Psychosocial Factors in ICI-Treated Cancer Patients · recruiting
- NCT06454903 — Developing a Smartphone Application to Support Veteran Opioid Use Disorder Treatment · NA · recruiting
- NCT06854822 — Siblings to a Child with Cancer: Needs and Pre-loss Grief · recruiting
- NCT06174701 — Building Resilience for Surgical Recovery · NA · recruiting
- NCT06242964 — The PRISM-Social Needs (PRISM-SN) Intervention for Adolescents and Young Adults With Cancer · NA · recruiting
Other Action Contre la Faim trials
Trials by the same sponsor.
- NCT03400930 — Biomedical Investigations for Optimized Diagnosis and Monitoring of Severe Acute Malnutrition (SAM): Elucidating the Het · completed
- NCT02672982 — Follow Up of Severely Malnourished Children (FUSAM) · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05281575 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Action Contre la Faim
- Last refreshed: 16 March 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05281575.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing